#shanghai stock exchange

2 stories

#finance #50 billion yuan #75 billion yuan #ai models #business #deepseek #delisting risk warning #financial losses #funding round #ipo #jindike #markets

Jindike's flu vaccine approval risks delisting
China's Jindike gets flu shot approval but may miss revenue target, risking stock delisting.
BigGo Finance · 1m
DeepSeek Hits $1 Billion Revenue Run Rate
DeepSeek doubles annual revenue run rate to $1 billion ahead of Shanghai Stock Exchange IPO.
Pymnts · 1m